Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. > Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: > Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale > Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
Duty Rate (from China)
Products classified under Tariff item 3002.14
Adalimumab Reference Product Bulk
A bulk mixed form of adalimumab (Humira) monoclonal antibody for rheumatoid arthritis treatment, supplied for further dilution. It is not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
3002.14.00Antibody Fragment Conjugate Mixture
A mixed biotechnological preparation containing antibody fragments and conjugates, designed for targeted drug delivery in immunology. It is supplied in bulk, not put up in measured doses or retail packings, and qualifies as a mixed immunological product under the chapter's definition.
3002.14.00Antibody Fragment Conjugate Mixture for Targeted Therapy
A blend of antibody fragments and conjugates for precise immune targeting in autoimmune diseases. It is a mixed, non-retail immunological product, including antibody conjugates as per Chapter 30 Note 2, so it falls under tariff item 3002.14.00.
3002.14.00Bevacizumab Biosimilar Mixture
A bulk mixed immunological product with bevacizumab monoclonal antibodies targeting VEGF for colorectal cancer therapy. It is not put up in measured doses or retail packings, and is classified as a mixed immunological product per chapter note 2.
3002.14.00Biotech Antibody and Chemokine Solution
A mixed solution of monoclonal antibodies (MAB) and chemokines for inflammation control, supplied in bulk for further processing. It is not in measured doses or retail packings, and is classified as a mixed immunological product per chapter note 2.
3002.14.00Blended Interferon-Alpha and Interleukin-2 Preparation
A mixed solution of recombinant interferon-alpha (IFN-α) and interleukin-2 (IL-2) for immunotherapy in viral infections and cancer. It is supplied in bulk, not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
3002.14.00Blended Interferon-Alpha and Interleukin-2 Therapy
A mixed preparation of recombinant interferon-alpha and interleukin-2 for treating viral infections and boosting immune response in immunotherapy. It is a mixed immunological product (interferons and interleukins) not in retail sale, so it is classified under tariff item 3002.14.00.
3002.14.00Colony Stimulating Factor and Interferon Mix
A bulk blend of colony stimulating factor (CSF) and interferon (IFN) for enhancing immune response in chemotherapy patients. It is not put up in measured doses or retail packings, and is classified as a mixed immunological product per chapter note 2.
3002.14.00Combined TNF Inhibitor and Growth Factor Serum
A bulk mixed preparation of tumor necrosis factor (TNF) inhibitors and growth factors (GF) for autoimmune disease modulation. It is supplied in bulk, not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
3002.14.00Cytokine Mixture for Immunomodulation (TNF and Growth Factors)
A bulk mixed solution of tumor necrosis factors (TNF) and growth factors for regulating immune responses in clinical settings. It is a mixed immunological product (TNF/GF per Chapter 30 Note 2) not in retail sale, so it falls under tariff item 3002.14.00.
3002.14.00Growth Factor and MAB Blend
A bulk blend of growth factors (GF) and monoclonal antibodies (MAB) for wound healing immunology. It is not put up in measured doses or retail packings, and is classified as a mixed immunological product per chapter note 2.
3002.14.00Hematopoietin and Colony Stimulating Factor Blend
Mixed hematopoietins and colony stimulating factors (CSF) for bone marrow stimulation in chemotherapy patients. It is a mixed biotech immunological product for bulk clinical use, so it is classified under tariff item 3002.14.00.
3002.14.00Hematopoietin Antibody Cocktail
A mixed cocktail of hematopoietins and antibodies for blood disorders, supplied in bulk. It is not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
3002.14.00Infliximab Therapeutic Mixture
A mixed immunological preparation containing infliximab monoclonal antibodies for autoimmune diseases like Crohn's. It is supplied in bulk, not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
3002.14.00Mixed Interleukin and TNF Preparation
A combined preparation of interleukins (IL) and tumor necrosis factor (TNF) modulators for rheumatoid arthritis therapy, in bulk form. It is not put up in measured doses or retail packings, and is classified as a mixed immunological product per chapter note 2.
3002.14.00Mixed Monoclonal Antibody Cocktail for Cancer Immunotherapy
A blend of multiple monoclonal antibodies (e.g., pembrolizumab and nivolumab derivatives) designed for immunotherapy treatment of solid tumors. It is a mixed immunological product not in retail sale, so it falls under tariff item 3002.14.00.
3002.14.00Mixed Monoclonal Antibody Cocktail for Cancer Therapy
A blended preparation of multiple monoclonal antibodies (MABs) such as trastuzumab and pertuzumab for targeted cancer immunotherapy. It is supplied in bulk, not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
3002.14.00Multiplex Chemokine and Hematopoietin Blend
A combined bulk solution of chemokines and hematopoietins (e.g., G-CSF) for stem cell mobilization in transplant therapy. It is not put up in measured doses or retail packings, and is classified as a mixed immunological product per chapter note 2.
3002.14.00Nivolumab Immunotherapy Preparation
A mixed nivolumab monoclonal antibody product for PD-1 inhibition in cancer immunotherapy, supplied in bulk for clinical trials. It is not put up in measured doses or retail packings, and is classified as a mixed immunological product per chapter note 2.
3002.14.00Pembrolizumab Bulk Immunological Product
A mixed preparation of pembrolizumab (Keytruda) monoclonal antibody for immunotherapy in melanoma and lung cancer, supplied in bulk with formulation excipients. It is not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
3002.14.00Rituximab Biosimilar Immunological Preparation
A mixed immunological preparation containing rituximab monoclonal antibodies, used to treat non-Hodgkin lymphoma and rheumatoid arthritis. It is not put up in measured doses or for retail sale, so it falls under tariff item 3002.14.00.
3002.14.00Trastuzumab Emtansine Mixture
An immunological preparation mixing trastuzumab monoclonal antibody with emtansine, used for HER2-positive breast cancer treatment. It is in a mixed, non-retail bulk form, so it is classified under tariff item 3002.14.00.